PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment
Clinical and Molecular Hepatology · 06.11.2026
DOI: 10.3350/cmh.2026.0822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 06.11.2026. Verfasst von Qin Zheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Science….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, Liaoning, China.
- Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China. liumulin87@126.com.
Zitieren
APA
Zheng, Q., & Liu, M. (2026). PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0822
Vancouver
Zheng Q, Liu M. PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0822
BibTeX
@article{Zheng2026,
author = {Zheng, Qin and Liu, Mulin},
title = {PI3K pathway activation as a predictive biomarker in biliary tract cancer: the importance of strict covariate adjustment},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0822}
}
EUVIMED